Sign in
  1. Home
  2. Companies
  3. CME Group
  4. Financial Ratios
CME Group logo
CME Group CME
$ 256.42 0.43%
report update icon

Quarterly report 2026-Q2
added 07-24-2026

CME Group Financial Ratios 2025-2006 | CME

Brief overview of CME Group 's market valuation

Ratios are assessed across five available annual reports in the 2021–2025 interval.

The latest available valuation ratios are P/E 27.93x (median 25.46x), P/B 3.96x (median 3.09x), P/CF 26.6x (median 24.32x). The multiple basket looks neutral against its history, differing from median levels by roughly +9.7%.

Earnings yield calculated as 1/P/E is about 3.6%, showing current profit per unit of share price.

End-period return metrics are ROE 14.2%, ROA 2.1%, ROCE 14.7%. Profitability remains positive and sufficient for normal operations without indicating exceptional efficiency.

PEG is 3.02x. Price is well ahead of embedded growth, making market expectations demanding.

Financial-company multiples cannot be compared directly with industrial businesses; P/B and sustainable capital returns remain central.

Overall picture

CME Group 's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.

Annual Financial Ratios CME Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

P/E

 27.9 25.5 24.5 24.7 32.1 33.0 36.9 31.5 12.8 26.5 24.2 25.3 25.3 21.5 8.8 21.7 5.3 6.8 7.1 -

P/S

 17.4 14.6 14.2 13.3 18.1 14.2 16.1 14.3 14.2 11.3 9.1 9.2 8.4 6.6 4.9 6.9 1.7 1.9 2.7 -

EPS

 11.2 9.7 8.9 7.4 7.3 5.9 5.9 5.7 12 4.5 3.7 3.4 2.9 2.7 5.5 2.9 12.4 12.2 15.1 -

EV (Enterprise Value)

 279 B 198 B 179 B 211 B 251 B 166 B 126 B 112 B 103 B 87.8 B 75.3 B 78.5 B 55.4 B 35.1 B 34.1 B 34.7 B 20.5 B 34 B 3.85 B -970 M

EBITDA per Share

 12.1 11.3 9.92 8.78 7.79 7.8 8.57 8.34 7.44 7.19 6.59 5.99 5.64 5.87 7.28 5.92 25.9 29.3 26.5 -

EV/EBITDA

 64.3 48.9 50.3 67.0 89.9 21.7 26.2 22.5 38.3 32.4 29.9 34.9 13.4 10.5 7.0 17.7 11.9 19.8 3.3 -

PEG

 3.02 4.23 6.35 6.71 17.55 8.99 10.58 -0.6 0.08 1.17 2.4 1.73 2.98 -0.43 0.1 - - - - -

P/B

 4.0 3.4 3.0 2.5 3.1 2.6 3.0 2.4 2.3 2.0 1.5 1.4 1.2 0.9 0.7 1.0 0.2 0.3 - -

P/CF

 26.6 24.3 22.9 21.8 35.3 25.6 32.2 26.6 29.5 25.0 21.6 24.8 21.4 17.9 13.6 15.2 4.0 4.0 5.8 -

ROE %

 14.17 13.31 12.07 10.01 9.62 7.99 8.09 7.56 18.13 7.54 6.07 5.39 4.62 4.18 8.38 4.74 4.28 3.83 5.35 -

ROA %

 2.05 2.57 2.49 1.54 1.34 1.69 2.81 2.53 5.36 2.21 1.85 1.56 1.80 2.31 4.45 2.71 2.32 1.49 - -

ROCE %

 14.72 14.84 12.85 11.22 9.65 10.01 7.05 7.20 7.68 7.24 6.51 5.76 5.29 5.42 6.94 9.13 8.23 8.47 8.55 -

Current Ratio

 1.2 1.2 1.3 1.2 1.2 1.3 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 1.1 2.3 2.2 1.6 - -

DSO

 33.9 33.0 33.3 33.4 34.9 35.6 36.9 46.9 36.0 37.0 39.3 40.0 37.6 33.5 32.2 33.2 33.7 16.7 - -

DPO

 30.5 36.6 46.7 41.2 25.8 28.0 25.1 63.0 19.5 16.8 18.0 23.1 23.8 28.4 16.3 41.6 61.2 40.8 - -

Operating Cycle

 33.9 33.0 33.3 33.4 34.9 35.6 36.9 46.9 36.0 37.0 39.3 40.0 37.6 33.5 32.2 33.2 33.7 16.7 - -

Cash Conversion Cycle

 3.4 -3.6 -13.4 -7.9 9.1 7.7 11.7 -16.1 16.6 20.2 21.2 17.0 13.8 5.1 15.9 -8.4 -27.5 -24.1 - -

All numbers in USD currency

Quarterly Financial Ratios CME Group

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1 2009-Q3 2009-Q2

EPS

 2.89 3.25 2.49 2.81 2.63 2.51 2.43 2.35 2.06 2.14 2.43 - 1.87 1.82 1.96 - 2.59 1.42 1.6 1.18 1.15 1.41 2.14 1.31 1.78 1.44 1.39 1.1 1.21 1.67 1.76 8.67 0.91 1.23 1.18 1.1 1.4 0.95 1.09 0.87 1.07 0.79 0.98 0.91 0.87 0.79 0.8 0.58 0.71 0.94 0.71 0.5 0.66 0.74 0.81 2.26 0.95 0.88 1.37 3.67 4.13 3.63 3.05 3.34

EBITDA per Share

 3.15 3.72 2.78 3.22 3.16 2.93 2.86 2.75 2.37 2.43 2.63 - 2.16 2.18 2.49 - 1.82 1.99 2.13 - 1.58 1.88 2.78 - 2.03 2.09 1.86 - 1.71 2.05 2.27 - 1.75 1.87 1.86 - 1.65 1.76 1.8 - 1.63 1.57 1.61 - 1.38 1.34 1.46 - 1.31 1.63 1.32 - 1.3 1.52 1.47 - 1.82 1.7 8.3 7.15 8.35 6.75 6.53 6.47

ROE %

 15.18 14.79 13.69 13.66 13.12 12.25 11.81 11.84 11.09 10.99 11.59 8.36 10.27 7.87 10.03 7.47 9.07 7.24 7.25 8.00 8.18 9.05 9.11 8.10 7.79 6.94 7.16 7.57 19.20 18.99 18.66 18.13 6.85 7.80 7.52 7.54 7.13 6.55 6.27 6.07 6.11 5.75 5.72 5.39 4.83 4.57 4.78 4.62 4.48 4.38 4.05 4.18 6.87 7.32 7.54 8.41 6.18 6.11 5.99 4.93 4.87 1.25 1.06 1.17

ROA %

 2.16 2.23 2.32 2.55 2.63 2.62 2.47 2.29 2.02 1.77 1.75 1.22 1.51 1.13 1.48 1.14 1.48 1.31 1.43 1.69 1.97 2.49 2.77 2.81 2.69 2.37 2.42 2.53 5.91 5.79 5.61 5.36 2.02 2.30 2.21 2.21 2.11 1.96 1.89 1.85 1.84 1.71 1.68 1.56 1.49 1.53 1.73 1.80 1.87 2.00 2.05 2.31 3.71 3.92 4.01 4.45 3.34 3.36 3.32 2.75 2.60 0.68 0.55 0.58

ROCE %

 16.62 16.54 15.25 15.42 14.88 13.70 13.08 12.80 11.88 12.06 11.30 7.96 10.48 7.87 10.60 7.50 9.46 9.20 9.10 10.02 10.25 10.88 11.13 9.90 10.21 9.71 9.61 10.06 9.95 10.36 10.49 10.31 10.57 10.62 10.69 10.83 10.46 10.39 10.03 9.68 9.64 9.19 8.75 8.45 7.73 7.56 7.99 7.74 7.96 7.92 7.71 7.90 7.96 8.76 9.05 9.38 9.79 9.79 9.48 9.14 9.02 2.16 2.10 2.10

Current Ratio

 1.2 1.1 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.2 1.2 1.2 1.2 - 1.2 1.2 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.6 1.6 1.6 1.6 2.2 2.2 2.2 2.2 2.1 2.1 2.1 2.1 2.5 2.3 2.2 2.1 2.0

DSO

 45.1 38.3 38.9 38.8 38.9 35.4 36.5 36.4 39.5 44.4 38.2 - 21.6 22.4 35.4 - 40.3 40.9 36.7 38.3 39.0 35.6 28.6 39.4 35.1 35.3 40.4 40.8 55.8 47.6 37.6 36.5 36.9 35.5 35.5 36.4 39.5 36.7 35.3 40.1 38.4 39.8 37.8 37.0 40.8 42.6 37.8 40.2 38.6 33.9 36.2 36.9 35.7 30.7 32.8 35.9 30.2 31.5 34.2 41.3 36.3 38.2 38.3 -

DPO

 28.0 30.8 32.1 39.6 50.8 47.9 47.0 36.5 23.2 32.9 48.8 - 22.9 19.9 31.9 - 27.1 21.3 24.5 - 29.2 29.1 28.9 - 25.3 24.9 35.2 - 73.0 70.2 44.0 - 20.2 20.4 18.4 - 18.3 18.1 19.0 - 19.2 18.5 21.2 - 25.5 24.1 24.6 - 24.6 25.6 27.5 - 32.4 29.0 24.6 - 23.7 24.1 27.9 33.6 32.7 33.4 39.0 -

Operating Cycle

 - 38.3 41.9 - 38.9 35.4 36.5 36.4 39.5 44.4 38.2 - 21.6 22.4 35.4 - 40.3 40.9 36.7 38.3 39.0 35.6 28.6 39.4 35.1 35.3 40.4 40.8 55.8 47.6 37.6 36.5 36.9 35.5 35.5 36.4 39.5 36.7 35.3 40.1 38.4 39.8 37.8 37.0 40.8 42.6 37.8 40.2 38.6 33.9 36.2 36.9 35.7 30.7 32.8 35.9 30.2 31.5 - - - - - -

Cash Conversion Cycle

 - 7.5 8.3 - -11.9 -12.5 -10.5 -0.1 16.2 11.5 -10.6 - -1.3 2.6 3.4 - 13.1 19.6 12.2 38.3 9.7 6.5 -0.3 39.4 9.9 10.4 5.2 40.8 -17.2 -22.5 -6.5 36.5 16.7 15.1 17.1 36.4 21.2 18.5 16.3 40.1 19.2 21.3 16.7 37.0 15.3 18.5 13.2 40.2 14.0 8.2 8.7 36.9 3.4 1.6 8.2 35.9 6.5 7.3 - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company CME Group , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Financial data industry

Issuer Price % 24h Market Cap Country
Московская Биржа Московская Биржа
MOEX
 		- - - russiaRussia
Nasdaq Nasdaq
NDAQ
 		$ 93.7 1.74 % $ 53.7 B usaUSA
B. Riley Financial B. Riley Financial
RILY
 		$ 6.62 -3.77 % $ 202 M usaUSA
S&P Global S&P Global
SPGI
 		- - $ 106 B usaUSA
Voya Financial Voya Financial
VOYA
 		- - $ 9.42 B usaUSA
Cohen & Company Cohen & Company
COHN
 		$ 13.4 -0.45 % $ 23.2 M usaUSA
Cboe Global Markets Cboe Global Markets
CBOE
 		$ 286.91 0.65 % $ 30 B usaUSA
Moody's Corporation Moody's Corporation
MCO
 		$ 490.78 4.09 % $ 87.9 B usaUSA
Intercontinental Exchange Intercontinental Exchange
ICE
 		$ 147.82 1.39 % $ 84.6 B usaUSA
MSCI MSCI
MSCI
 		- - $ 43.5 B usaUSA
FactSet Research Systems FactSet Research Systems
FDS
 		$ 269.85 6.08 % $ 10.2 B usaUSA
Morningstar Morningstar
MORN
 		- - $ 7.73 B usaUSA
Jefferies Financial Group Jefferies Financial Group
JEF
 		$ 55.42 -0.78 % $ 11.9 B usaUSA
Value Line Value Line
VALU
 		$ 37.54 -0.69 % $ 354 M usaUSA
Siebert Financial Corp. Siebert Financial Corp.
SIEB
 		- - $ 67.8 M usaUSA